| For: | Duca I, Piscina PRL, Estrada S, Calderón R, Spicakova K, Urtasun L, Marra-López C, Zabaleta S, Bengoa R, Marcaide MA, García-Campos F. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab. World J Gastroenterol 2013; 19(4): 590-593 [PMID: 23382642 DOI: 10.3748/wjg.v19.i4.590] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i4/590.htm |
| Number | Citing Articles |
| 1 |
Stephan R. Vavricka, Martin Gubler, Claudine Gantenbein, Muriel Spoerri, Florian Froehlich, Frank Seibold, Marijana Protic, Pierre Michetti, Alex Straumann, Nicolas Fournier, Pascal Juillerat, Luc Biedermann, Jonas Zeitz, Benjamin Misselwitz, Michael Scharl, Henriette Heinrich, Christine N. Manser, Ekaterina Safroneeva, Raja Affendi Raja Ali, Gerhard Rogler, Alain M. Schoepfer, Thomas Greuter. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflammatory Bowel Diseases 2017; 23(7) doi: 10.1097/MIB.0000000000001109
|
| 2 |
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2022; 16(3) doi: 10.1080/17474124.2022.2036122
|
| 3 |
|
| 4 |
Teresa Del Ross, Amelia Ruffatti, Annarosa Floreani, Ariela Hoxha, Leonardo Punzi. The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report. BMC Musculoskeletal Disorders 2016; 17(1) doi: 10.1186/s12891-016-1335-x
|
| 5 |
JIA-LE SONG, YU QIAN, GUI-JIE LI, XIN ZHAO. Anti-inflammatory effects of kudingcha methanol extract (Ilex kudingcha C.J. Tseng) in dextran sulfate sodium-induced ulcerative colitis. Molecular Medicine Reports 2013; 8(4) doi: 10.3892/mmr.2013.1635
|
| 6 |
Irene Franceschet, Nora Cazzagon, Teresa Del Ross, Renata D’Incà, Alessandra Buja, Annarosa Floreani. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(5) doi: 10.1097/MEG.0000000000000596
|
| 7 |
Brigid Pinnuck, Kate D. Lynch. Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(13) doi: 10.1080/14656566.2024.2407022
|
| 8 |
Mitsuro Chiba, Hidehiko Tsuda, Satoko Tsuda, Masafumi Komatsu, Yasuo Horie, Hirohide Ohnishi. Normalization of Serum Alkaline Phosphatase in Primary Sclerosing Cholangitis Associated with Ulcerative Colitis. Health 2014; 6(10) doi: 10.4236/health.2014.610122
|
| 9 |
Kate D. Lynch, Satish Keshav, Roger W. Chapman. The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Current Hepatology Reports 2019; 18(1) doi: 10.1007/s11901-019-00456-2
|